Skip to main navigation
Skip to search
Skip to main content

Johns Hopkins University Home

Home
Profiles
Research units
Research output

Search by expertise, name or affiliation

Trametinib dimethyl sulfoxide. MAP kinase kinase 1 and 2 (MEK 1/2) inhibitor oncolytic

D. P. Cosgrove

Research output: Contribution to journal › Review article › peer-review

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'Trametinib dimethyl sulfoxide. MAP kinase kinase 1 and 2 (MEK 1/2) inhibitor oncolytic'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Medicine & Life Sciences

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2024 Elsevier B.V. or its licensors and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility

Report vulnerability